PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Steve Yoder on Q1 2021 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc. (PIRS) Q1 2021 Earnings Conference Call May 17, 2021 08:00 AM ET Company Participants Tom Bures - Vice President, Finance Steve Yoder - President & Chief Executive Officer Shane Olwill - Senior Vice President & Head, Translational Science Conference Call Participants Umer Raffat - Evercore Matt Phipps - William Blair Presentation Operator Greetings, and welcome to Pieris Pharmaceuticals' Q1 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now turn the conference over to your host, Tom Bures, Vice President, Finance. You go ahead. Tom Bures Thank you. Good morning, everyone, and thank you for joining us for our year-end 2020 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate overview
For further details see:
Pieris Pharmaceuticals, Inc. (PIRS) CEO Steve Yoder on Q1 2021 Results - Earnings Call Transcript